Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1219

    1.

    Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis.

    Alvaro D, Macarri G, Mancino MG, Marzioni M, Bragazzi M, Onori P, Corradini SG, Invernizzi P, Franchitto A, Attili AF, Gaudio E, Benedetti A.

    Ann Intern Med. 2007 Oct 2;147(7):451-9. Erratum in: Ann Intern Med. 2007 Nov 6;147(9):676. PMID: 17909206 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.

    Leelawat K, Sakchinabut S, Narong S, Wannaprasert J.

    BMC Gastroenterol. 2009 Apr 30;9:30.PMID: 19405942 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The value of biliary fibronectin for diagnosis of cholangiocarcinoma.

    Chen CY, Lin XZ, Tsao HC, Shiesh SC.

    Hepatogastroenterology. 2003 Jul-Aug;50(52):924-7.PMID: 12845951 [PubMed - indexed for MEDLINE]Related articles

    4.

    Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.

    Nakeeb A, Lipsett PA, Lillemoe KD, Fox-Talbot MK, Coleman J, Cameron JL, Pitt HA.

    Am J Surg. 1996 Jan;171(1):147-52; discussion 152-3.PMID: 8554130 [PubMed - indexed for MEDLINE]Related articles

    5.

    Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP.

    Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, Lee JH, Kim KA, Kim AY, Kim PN, Lee MG, Ha HK.

    Radiology. 2004 Oct;233(1):234-40. Epub 2004 Aug 27.PMID: 15333766 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Vascular endothelial growth factor and insulin-like-growth factors in prostate cancer. ]

    Trapeznikova MF, Shibaeva AN, Ianshin AA, Urenkov SB, Mironova OS, Kazantseva IA, Kushlinskiĭ NE.

    Urologiia. 2004 Jan-Feb;(1):17-21. Russian. PMID: 15022438 [PubMed - indexed for MEDLINE]Related articles

    7.

    Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.

    Scarlett CJ, Saxby AJ, Nielsen A, Bell C, Samra JS, Hugh T, Baxter RC, Smith RC.

    Hepatology. 2006 Sep;44(3):658-66.PMID: 16941699 [PubMed - indexed for MEDLINE]Related articles

    8.

    The value of biliary amylase and Hepatocarcinoma-Intestine-Pancreas/Pancreatitis-associated Protein I (HIP/PAP-I) in diagnosing biliary malignancies.

    Chen CY, Lin XZ, Wu HC, Shiesh SC.

    Clin Biochem. 2005 Jun;38(6):520-5.PMID: 15885230 [PubMed - indexed for MEDLINE]Related articles

    9.

    Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma.

    Koopmann J, Thuluvath PJ, Zahurak ML, Kristiansen TZ, Pandey A, Schulick R, Argani P, Hidalgo M, Iacobelli S, Goggins M, Maitra A.

    Cancer. 2004 Oct 1;101(7):1609-15.PMID: 15378479 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.

    Kim HJ, Kim MH, Myung SJ, Lim BC, Park ET, Yoo KS, Seo DW, Lee SK, Min YI.

    Am J Gastroenterol. 1999 Jul;94(7):1941-6.PMID: 10406263 [PubMed - indexed for MEDLINE]Related articles

    11.

    Serum and bile biomarkers for cholangiocarcinoma.

    Alvaro D.

    Curr Opin Gastroenterol. 2009 May;25(3):279-84. Review.PMID: 19396965 [PubMed - indexed for MEDLINE]Related articles

    12.

    Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: a follow-up study of more than 1,000 patients.

    Tocchi A, Mazzoni G, Liotta G, Lepre L, Cassini D, Miccini M.

    Ann Surg. 2001 Aug;234(2):210-4.PMID: 11505067 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Increased intercellular adhesion molecule-1 serum concentration in cholestasis.

    Polzien F, Ramadori G.

    J Hepatol. 1996 Dec;25(6):877-86.PMID: 9007716 [PubMed - indexed for MEDLINE]Related articles

    14.

    A comparison of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the differential diagnosis of benign and malignant jaundice and cholestasis.

    Pasanen PA, Partanen KP, Pikkarainen PH, Alhava EM, Janatuinen EK, Pirinen AE.

    Eur J Surg. 1993 Jan;159(1):23-9.PMID: 8095802 [PubMed - indexed for MEDLINE]Related articles

    15.

    Diagnostic role of biliary pancreatic elastase for cholangiocarcinoma in patients with cholestasis.

    Chen CY, Tsai WL, Wu HC, Syu MJ, Wu CC, Shiesh SC.

    Clin Chim Acta. 2008 Apr;390(1-2):82-9. Epub 2008 Jan 16.PMID: 18252202 [PubMed - indexed for MEDLINE]Related articles

    16.

    [MR cholangiopancreatography: technique, indications and clinical results]

    Pavone P, Laghi A, Panebianco V, Catalano C, Passariello R.

    Radiol Med. 1997 Dec;94(6):632-41. Italian. PMID: 9524602 [PubMed - indexed for MEDLINE]Related articles

    17.

    EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results.

    DeWitt J, Misra VL, Leblanc JK, McHenry L, Sherman S.

    Gastrointest Endosc. 2006 Sep;64(3):325-33.PMID: 16923477 [PubMed - indexed for MEDLINE]Related articles

    19.

    Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.

    Ahrendt SA, Pitt HA, Nakeeb A, Klein AS, Lillemoe KD, Kalloo AN, Cameron JL.

    J Gastrointest Surg. 1999 Jul-Aug;3(4):357-67; discussion 367-8.PMID: 10482687 [PubMed - indexed for MEDLINE]Related articles

    20.

    Bile levels of carcino-embryonic antigen in patients with hepatopancreatobiliary disease.

    Buffet C, Fourré C, Altman C, Prat F, Fritsch J, Choury A, Briantais MJ, Desgrez A, Etienne JP.

    Eur J Gastroenterol Hepatol. 1996 Feb;8(2):131-4.PMID: 8723416 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data